Related Experiment Video
Updated: May 20, 2026

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
Sensitizing cancer cells: is it really all about U?
Patrick J Stover1, Robert S Weiss
1Division of Nutritional Sciences, Cornell University, Ithaca, New York 14853, USA. pjs13@cornell.edu
Abstract:
In this issue of Cancer Cell, Hu et al. report that TMPK and RNR, two key enzymes in deoxyribonucleotide biosynthesis, co-localize to damaged DNA and produce nucleotides necessary for DNA repair while suppressing uracil incorporation. TMPK inhibition disrupts this balance and selectively sensitizes cancer cells to low-dose chemotherapy.
Insights
Two key enzymes, thymidine monophosphate kinase (TMPK) and ribonucleotide reductase (RNR), support DNA repair at damaged sites. Inhibiting TMPK selectively sensitizes cancer cells to chemotherapy by disrupting this process.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Deoxyribonucleotide biosynthesis is crucial for DNA replication and repair.
- Thymidine monophosphate kinase (TMPK) and ribonucleotide reductase (RNR) are key enzymes in this pathway.
- Maintaining nucleotide balance is essential for genomic stability.
Discussion:
- Hu et al. demonstrate that TMPK and RNR localize to DNA damage sites.
- These enzymes produce necessary nucleotides for DNA repair.
- They also suppress the incorporation of uracil into DNA, preventing mutations.
Key Insights:
- TMPK inhibition disrupts the balance of nucleotide synthesis and DNA repair.
- This disruption leads to selective sensitization of cancer cells to chemotherapy.
- Targeting TMPK offers a potential strategy for enhancing cancer treatment efficacy.
Outlook:
- Further research into TMPK as a therapeutic target is warranted.
- Combination therapies involving TMPK inhibitors and chemotherapy could improve patient outcomes.
- Understanding the precise mechanisms of TMPK in DNA repair may reveal new avenues for cancer drug development.
Related Concept Videos
Cancer
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Mitogens and the Cell Cycle
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells
Somatic cells are...

